Page 35 - The Insurance Times November 2025
P. 35

advanced models, such as PhenoAge (Levine et al., 2018)  robust  tools  for  mortality  prediction,  surpassing
          and GrimAge (Lu et al., 2019), were designed not only to  conventional actuarial risk measures in certain contexts.
          predict chronological age but also to incorporate mortality-
          associated biomarkers, thereby directly linking epigenetic  4.  Application  in  Life  Insurance  Risk
          changes to life expectancy.
                                                              Stratification

          2.3 Types of Epigenetic Clocks                      4.1 Advantages to Insurers
          Epigenetic clocks can be broadly categorized into:  The integration of epigenetic clocks into life insurance
             First-generation clocks (Horvath, Hannum): Focused  underwriting could provide several advantages:
             on predicting chronological age.                 1. Precision in Risk Assessment: Epigenetic clocks offer
                                                                 individualized  risk  profiles  beyond  demographic
             Second-generation  clocks  (PhenoAge,  GrimAge):
             Designed  to  predict  healthspan  and  mortality by  averages.
             integrating clinical biomarkers and surrogate markers  2. Early  Detection  of  Risk:  Identifying  accelerated
             (e.g., smoking pack-years, plasma proteins).        biological aging could signal higher risk individuals even
                                                                 before clinical disease onset.
             Next-generation clocks: Aim to capture additional
             features such as tissue-specific aging, stress response,  3. Dynamic  Monitoring: Unlike  static  demographic
             and disease-specific methylation patterns.          factors, biological age can change over time, enabling
                                                                 continuous policy adjustments.
          3.  Epigenetic  Clocks  and  Mortality              4. Competitive Differentiation: Early adoption could allow
          Prediction                                             insurers to design innovative, personalized products.
          3.1 Scientific Validation                           For  example,  a  policyholder  with  a  biological  age
          Numerous cohort studies have validated the utility of  significantly younger than their chronological age may
          epigenetic clocks in predicting all-cause mortality. For  qualify for lower premiums, while those with accelerated
          instance, accelerated epigenetic aging, where biological  aging may be flagged for higher risk. This granular approach
          age  exceeds chronological age, has been consistently  has the potential to revolutionize risk stratification models.
          associated with increased mortality risk (Marioni et al.,
          2015). GrimAge, in particular, outperforms earlier clocks, 5. Ethical and Legal Considerations
          with studies showing that it can predict time-to-death,  The application of epigenetic clocks in life insurance raises
          incidence of cancer, cardiovascular disease, and other age-  several ethical and legal concerns:
          related morbidities (Lu et al., 2019).                 Genetic and Epigenetic Discrimination: Similar to
                                                                 debates around genetic testing, the use of epigenetic
          3.2 Key Findings                                       data may lead to discrimination in access to insurance
             Epigenetic age acceleration correlates with all-cause  or unfair premium rates.
             mortality independent of lifestyle and genetic factors  Informed Consent: Individuals must fully understand
             (Marioni et al., 2015).                             the implications of sharing molecular data, including
             GrimAge predicts  mortality more  accurately than   potential consequences for insurability.
             traditional risk factors such as smoking and body mass  Privacy Concerns: DNA  methylation  profiles  may
             index (McCrory et al., 2021).                       inadvertently reveal information about lifestyle factors
             PhenoAge  demonstrates strong  associations  with   (e.g., smoking, alcohol use) or disease predispositions,
             morbidity, frailty, and longevity, offering utility beyond  necessitating stringent data protection measures.
             chronological age prediction (Levine et al., 2018).  Regulatory Oversight: Current legal frameworks often
             Epigenetic clocks have shown predictive consistency  address genetic data but may not extend to epigenetic
             across  populations,  though  with  variations  in  information, creating regulatory gaps.
             accuracy depending on ancestry and environmental    Social  Equity:  There  is  a  risk  that  marginalized
             exposures.                                          populations could be disproportionately affected,
                                                                 particularly if socioeconomic stressors are reflected in
          Collectively, these findings confirm that epigenetic clocks are  accelerated epigenetic aging.


         32    November 2025  The Insurance Times
   30   31   32   33   34   35   36   37   38   39   40